Bret Holguin, M.S.

Bret Holguin, M.S. has extensive experience in research and development. Bret began their career in 1998 as a M.S. Student and Research Assistant at the City of Hope/Beckman Research Institute. In 2001, they moved to UC Irvine as a Staff Research Associate II in the Ophthalmology Research lab. In 2006, they joined NGI (LabCorp subsidiary) as a Research Associate. From 2007 to 2017, they worked at Allergan as a Scientist in the Neurotoxin group, where they performed 80% of the bench work and data analysis, designed primers to introduce random combinations of mutations, developed assay conditions, and identified a lead candidate. In 2017, they joined Amprion Inc. as a Research Associate.

Bret Holguin, M.S. earned a Master of Science degree in Biology from California State University, Los Angeles in 2000.